28241801|t|The protective effects of propofol against CoCl2-induced HT22 cell hypoxia injury via PP2A/CAMKIIalpha/nNOS pathway.
28241801|a|BACKGROUND: Perioperative cerebral ischemia/hypoxia could induce hippocampal injury and has been reported to induce cognitive impairment. In this study, we used cobalt chloride (CoCl2) to build a hypoxia model in mouse hippocampal cell lines. Propofol, a widely used intravenous anesthetic agent, has been demonstrated to have neuroprotective effect. Here, we explored whether and how propofol attenuated CoCl2-induced mouse hippocampal HT22 cell injury. METHODS: Mouse hippocampal HT22 cells were pretreated with propofol, and then stimulated with CoCl2. Cell viability was measured by cell counting kit 8 (CCK8). The effect of propofol on CoCl2-modulated expressions of B-cell lymphoma 2 (Bcl-2), BAX, cleaved caspase 3, phosphatase A2 (PP2A), and the phosphorylation of Ca2+/Calmodulin (CaM)-dependent protein kinase II (pCAMKIIalpha), neuron nitric oxide synthase at Ser1412 (pnNOS-Ser1412), neuron nitric oxide synthase at Ser847 (pnNOS-Ser847) were detected by Western blot analysis. RESULTS: Compared with control, CoCl2 treatment could significantly decrease cell viability, which could be reversed by propofol. Further, we found CoCl2 treatment could up-regulate the expression of PP2A, BAX, cleaved caspase three and cause the phosphorylation of nNOS-Ser1412, but it down-regulated the expression of Bcl-2 and the phosphorylation of CAMKIIalpha and nNOS-Ser847. More importantly, these CoCl2-mediated effects were attentuated by propofol. In addition, we demonstrated that propofol could exert similar effect to that of the PP2A inhibitor (okadaic acid). Further, the PP2A activator (FTY720) and the CAMKIIalpha inhibitor (KN93) could reverse the neuroprotective effect of propofol. CONCLUSION: Our data indicated that propofol could attenuate CoCl2-induced HT22 cells hypoxia injury via PP2A/CAMKIIalpha/nNOS pathway.
28241801	26	34	propofol	Chemical	MESH:D015742
28241801	43	48	CoCl2	Chemical	MESH:C018021
28241801	57	61	HT22	CellLine	CVCL:0321
28241801	67	81	hypoxia injury	Disease	MESH:D000860
28241801	86	90	PP2A	Gene	19052
28241801	103	107	nNOS	Gene	18125
28241801	143	160	cerebral ischemia	Disease	MESH:D002545
28241801	161	168	hypoxia	Disease	MESH:D000860
28241801	182	200	hippocampal injury	Disease	MESH:D001930
28241801	233	253	cognitive impairment	Disease	MESH:D003072
28241801	278	293	cobalt chloride	Chemical	MESH:C018021
28241801	295	300	CoCl2	Chemical	MESH:C018021
28241801	313	320	hypoxia	Disease	MESH:D000860
28241801	330	335	mouse	Species	10090
28241801	360	368	Propofol	Chemical	MESH:D015742
28241801	502	510	propofol	Chemical	MESH:D015742
28241801	522	527	CoCl2	Chemical	MESH:C018021
28241801	536	541	mouse	Species	10090
28241801	554	558	HT22	CellLine	CVCL:0321
28241801	564	570	injury	Disease	MESH:D014947
28241801	581	586	Mouse	Species	10090
28241801	599	603	HT22	CellLine	CVCL:0321
28241801	631	639	propofol	Chemical	MESH:D015742
28241801	666	671	CoCl2	Chemical	MESH:C018021
28241801	746	754	propofol	Chemical	MESH:D015742
28241801	758	763	CoCl2	Chemical	MESH:C018021
28241801	789	806	B-cell lymphoma 2	Gene	12043
28241801	808	813	Bcl-2	Gene	12043
28241801	816	819	BAX	Gene	12028
28241801	829	838	caspase 3	Gene	12367
28241801	856	860	PP2A	Gene	19052
28241801	890	939	Ca2+/Calmodulin (CaM)-dependent protein kinase II	Gene	12325
28241801	1139	1144	CoCl2	Chemical	MESH:C018021
28241801	1227	1235	propofol	Chemical	MESH:D015742
28241801	1255	1260	CoCl2	Chemical	MESH:C018021
28241801	1307	1311	PP2A	Gene	19052
28241801	1313	1316	BAX	Gene	12028
28241801	1373	1377	nNOS	Gene	18125
28241801	1427	1432	Bcl-2	Gene	12043
28241801	1476	1480	nNOS	Gene	18125
28241801	1513	1518	CoCl2	Chemical	MESH:C018021
28241801	1556	1564	propofol	Chemical	MESH:D015742
28241801	1600	1608	propofol	Chemical	MESH:D015742
28241801	1651	1655	PP2A	Gene	19052
28241801	1667	1679	okadaic acid	Chemical	MESH:D019319
28241801	1695	1699	PP2A	Gene	19052
28241801	1711	1717	FTY720	Chemical	MESH:D000068876
28241801	1750	1754	KN93	Chemical	MESH:C072105
28241801	1800	1808	propofol	Chemical	MESH:D015742
28241801	1846	1854	propofol	Chemical	MESH:D015742
28241801	1871	1876	CoCl2	Chemical	MESH:C018021
28241801	1885	1889	HT22	CellLine	CVCL:0321
28241801	1896	1910	hypoxia injury	Disease	MESH:D000860
28241801	1915	1919	PP2A	Gene	19052
28241801	1932	1936	nNOS	Gene	18125
28241801	Association	MESH:D015742	19052
28241801	Association	MESH:D015742	18125
28241801	Positive_Correlation	MESH:D000068876	19052
28241801	Association	MESH:C018021	12325
28241801	Association	MESH:C018021	12367
28241801	Positive_Correlation	MESH:C018021	MESH:D014947
28241801	Association	MESH:D015742	12325
28241801	Positive_Correlation	MESH:C018021	MESH:D000860
28241801	Positive_Correlation	MESH:C018021	12028
28241801	Negative_Correlation	MESH:D019319	19052
28241801	Negative_Correlation	MESH:C018021	12043
28241801	Positive_Correlation	MESH:C018021	19052
28241801	Negative_Correlation	MESH:C072105	MESH:D015742
28241801	Positive_Correlation	MESH:C018021	18125
28241801	Negative_Correlation	MESH:D015742	MESH:D014947
28241801	Negative_Correlation	MESH:D015742	12043
28241801	Negative_Correlation	MESH:C018021	MESH:D015742
28241801	Negative_Correlation	MESH:D015742	MESH:D000860

